Replimune Group Inc

For the period ended Dec 31, 2023. Filed Feb 8, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2023 · Filed Feb 8, 2024

REPL$23.28+4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Amounts in thousands, except share amounts)

Common stock · Additionalpaid-incapital · Accumulateddeficit · Accumulatedothercomprehensiveloss · Totalstockholders’equity
Shares · Amount
Balances as of March 31, 2023	56,676,313	$57		$1,034,994			$(485,488)			$5,729			$555,292
Foreign currency translation adjustment	—	—	—		—			(1,305)			(1,305)
Unrealized loss on short-term investments	—	—	—		—		(458)			(458)
Exercise of pre-funded warrants	1,922,655	—		—			—		—		—
Exercise of stock options	96,146	—		1,209			—			—			1,209
Vesting of RSUs	281,211	—		—			—		—		—
Stock-based compensation expense	—	—	8,846			—		—		8,846
Net loss	—	—	—		(49,555)			—		(49,555)
Balances as of June 30, 2023	58,976,325	57		1,045,049			(535,043)			3,966			514,029
Foreign currency translation adjustment	—	—		—			—			1,308			1,308
Unrealized gain on short-term investments	—	—		—			—			214			214
Exercise of stock options	67,210	1		549			—			—			550
Vesting of RSUs	15,808	1		—			—			—			1
Stock-based compensation expense	—	—		9,114			—			—			9,114
Net loss	—	—		—			(60,044)			—			(60,044)
Balances as of September 30, 2023	59,059,343	59		1,054,712			(595,087)			5,488			465,172
Foreign currency translation adjustment	—	—		—			—			(1,288)			(1,288)
Unrealized gain on short-term investments	—	—		—			—			534			534
Exercise of pre-funded warrants	2,279,967	2		(4)			—			—			(2)
Vesting of RSUs	48,476	—		—			—			—			—
Stock-based compensation expense	—	—		8,241			—			—			8,241
Net loss	—	—		—			(51,120)			—			(51,120)
Balances as of December 31, 2023	61,387,786	$61		$1,062,949			$(646,207)			$4,734			$421,537
Balances as of March 31, 2022	47,338,660	$47		$723,359			$(311,204)			$(973)			$411,229
Issuance of common stock through ATM sales, net of offering costs	1,686,438	2		31,035			—		—		31,037
Foreign currency translation adjustment	—	—	—		—		1,737			1,737
Unrealized loss on short-term investments	—	—	—		—		(244)			(244)
Exercise of stock options	124,028	—		1,562			—		—		1,562
Vesting of RSUs	149,341	—		—			—		—		—
Stock-based compensation expense	—	—	7,194			—		—		7,194
Net loss	—	—	—		(42,253)			—		(42,253)
Balances as of June 30, 2022	49,298,467	49		763,150			(353,457)			520			410,262
Issuance of common stock through ATM sales, net of offering costs	340,000	1		6,400			—			—			6,401
Foreign currency translation adjustment	—	—		—			—			2,330			2,330
Unrealized gain on short-term investments	—	—		—			—			81			81
Exercise of stock options	88,252	—		1,108			—			—			1,108
Vesting of RSUs	12,688		—							—
Stock-based compensation expense	—	—		6,992			—			—			6,992
Net loss	—	—		—			(43,102)			—			(43,102)
Balances as of September 30, 2022	49,739,407	50		777,650			(396,559)			2,931			384,072
Issuance of prefunded warrants to purchase common stock	—	—		92,778			—			—			92,778
Issuance of common stock, net of issuance costs and underwriter fees	6,810,658	7		149,847			—			—			149,854
Foreign currency translation adjustment	—	—		—			—			158		158
Unrealized gain on short-term investments	—	—		—			—			650			650
Exercise of stock options	60,921	—		500			—			—			500
Vesting of RSUs	22,013	—		—							—
Stock-based compensation expense	—	—		7,023			—			—			7,023
Net loss	—	—		—			(39,690)			—			(39,690)
Balances as of December 31, 2022	56,632,999	$57		$1,027,798			$(436,249)			$3,739			$595,345

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.